Cargando…
Circulating blood miRNAs for prostate cancer risk stratification: miRroring the underlying tumor biology with liquid biopsies
Current risk stratification methods for prostate cancer – although they have seen marked improvements over the past decades – are far from perfect. Despite the significant utility of prostate-specific antigen as a biomarker to monitor for disease recurrence, it cannot predict which tumors will recur...
Autores principales: | Hoey, Christianne, Liu, Stanley K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398395/ https://www.ncbi.nlm.nih.gov/pubmed/30881943 http://dx.doi.org/10.2147/RRU.S165625 |
Ejemplares similares
-
MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction
por: Paiva, Solenne, et al.
Publicado: (2017) -
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016) -
miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance
por: Sbirkov, Yordan, et al.
Publicado: (2022) -
Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022) -
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
por: Roi, Alexandra, et al.
Publicado: (2023)